Brain Talks

NeuroTech Europe is a newly born project that would promote the interest of association members towards EU institutions (EU Commission, DG Research & Innovation, EU parliament) and the permanent representations of key EU member states. It aims to shape the research agenda, specifically increasing the number of calls related to neurotechnologies.In this conversation, Sebastian Haesler, creator of NeuroTech Europe, explains to us the goals and the purposes of the initiative.

Today the Brain Talks go back to basics: what is the driving force behind the need and creation of the Brain Innovation Days? At some point of their life, one in three Europeans will live with a brain disease – neurological and mental alike. As a result, the estimations are that brain disorders account for up to 45% of total healthcare budgets. This burden is expected to grow.We speak with Prof. Günther Deuschl, Professor of Neurology at Christian-Albrechts-Universität in Kiel, Germany and former

The European Medicines Agency (EMA) is a decentralised agency of the European Union (EU) responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU. The European Medicines Agency plays an important role in the innovation and availability of medicines for human and veterinary use through its support to research activities within the European Union (EU) and beyond.What is the role the EMA can play in facilitating innovation in brain research? Florence Butlen,

Helpilepsy enables better patient outcomes and improves care efficiency by registering seizures, side effects and medication online.Ludovic Ampe, Co-Founder & Strategic Growth Lead, explains the advantages that both patients and neurologists can gain from it.

Brain+ provides digital therapeutics for brain rehabilitation and remediation, specifically for the recovery of impaired cognitive functions due to injury or disease - combining neuro-games and digital behavioural therapy into powerful treatment solutions.It’s award winning Brain+ apps are being clinically tested in Parkinson’s disease, Major depressive disorder and Traumatic brain injury patients, and is being used by Danish national team athletes to enhance cognitive performance. Brain+ is also

Pierre Meulien, Executive Director of the Innovative Medicines Initiative (IMI) was one of the panelists at the Digital Launch of the Brain Innovation Days on 13 October 2020. With questions coming in from the audience and an exciting line-up of speakers, time flew by and the riveting discussion could have lasted hours! Join us now for an Overtime discussion with Pierre to explore the details and questions left unasked during the launch event.The IMI is a public-private partnership aiming to speed

Prof Monica Di Luca, President of European Brain Council, presents the first episode of Brain Talks, the podcast launched by Brain Innovation Days.